Stay updated on Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Sign up to get notified when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.

Latest updates to the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page
- Check2 days agoChange DetectedUpdated to v3.0.2 from v3.0.1. The Back to Top link has been removed.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check17 days agoChange DetectedThe page has added a facility name and location, specifically Newcastle upon Tyne, United Kingdom, while also introducing a new version revision (v3.0.0). However, it has removed several related terms and resources that may have provided context about genetic and rare diseases.SummaryDifference3%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.